Home Newsletters Hematopoiesis News Targeting Serine Hydroxymethyltransferases 1 and 2 for T-Cell Acute Lymphoblastic Leukemia Therapy

Targeting Serine Hydroxymethyltransferases 1 and 2 for T-Cell Acute Lymphoblastic Leukemia Therapy

0
Loss of both SHMT1 and SHMT2 was necessary for impaired growth and cell cycle arrest, with suppression of both SHMT1 and SHMT2 inhibiting leukemia progression in vivo.
[Leukemia]
7992332 {7992332:FCZHCSCR} apa 50 1 165225 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version